Pharmaceutical Industry Blog

Obiltoxaximab is a monoclonal antibody designed to treat and prevent inhalational anthrax, a severe and potentially fatal infection...

I-Omburtamab is an investigational monoclonal antibody designed to target the B7H3 (CD276) protein, which is overexpressed in various...

Ceralasertib is a novel oral ATR kinase inhibitor that is gaining attention in the field of oncology. This promising compound is being...

Anastrozole is a medication primarily used to treat breast cancer in postmenopausal women. It belongs to a class of drugs known as...

Aducanumab, sold under the brand name Aduhelm, is a groundbreaking drug that has generated significant debate and interest in the medical...

In the relentless battle against cancer, researchers continuously strive to find innovative treatments that offer hope to patients...